| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 410 | 2013 |
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia LH Meeter, EG Dopper, LC Jiskoot, R Sanchez‐Valle, C Graff, L Benussi, ... Annals of clinical and translational neurology 3 (8), 623-636, 2016 | 294 | 2016 |
| The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism EH Corder, E Ghebremedhin, MG Taylor, DR Thal, TG OHM, H Braak Annals of the New York Academy of Sciences 1019 (1), 24-28, 2004 | 269 | 2004 |
| Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ... The Lancet Neurology 17 (4), 335-346, 2018 | 224 | 2018 |
| Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia C Tesson, M Nawara, MAM Salih, R Rossignol, MS Zaki, M Al Balwi, ... The American Journal of Human Genetics 91 (6), 1051-1064, 2012 | 224 | 2012 |
| Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ... Neurology 90 (1), e22-e30, 2018 | 216 | 2018 |
| Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia E Martin, R Schüle, K Smets, A Rastetter, A Boukhris, JL Loureiro, ... The American Journal of Human Genetics 92 (2), 238-244, 2013 | 203 | 2013 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 195 | 2020 |
| Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias LC de Souza, F Lamari, S Belliard, C Jardel, C Houillier, R De Paz, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (3), 240-246, 2011 | 187 | 2011 |
| CSF tau markers are correlated with hippocampal volume in Alzheimer's disease LC De Souza, M Chupin, F Lamari, C Jardel, D Leclercq, O Colliot, ... Neurobiology of aging 33 (7), 1253-1257, 2012 | 161 | 2012 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 158 | 2019 |
| Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease LC De Souza, F Corlier, MO Habert, O Uspenskaya, R Maroy, F Lamari, ... Brain 134 (7), 2036-2043, 2011 | 157 | 2011 |
| Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ... Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018 | 153 | 2018 |
| Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy N Weiss, PB Saint Hilaire, B Colsch, F Isnard, S Attala, A Schaefer, ... Journal of hepatology 65 (6), 1120-1130, 2016 | 148 | 2016 |
| Two distinct amnesic profiles in behavioral variant frontotemporal dementia M Bertoux, LC de Souza, F Corlier, F Lamari, M Bottlaender, B Dubois, ... Biological psychiatry 75 (7), 582-588, 2014 | 130 | 2014 |
| Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE C Nava, F Lamari, D Héron, C Mignot, A Rastetter, B Keren, D Cohen, ... Translational psychiatry 2 (10), e179-e179, 2012 | 129 | 2012 |
| Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases F Lamari, F Mochel, F Sedel, JM Saudubray Journal of inherited metabolic disease 36 (3), 411-425, 2013 | 119 | 2013 |
| Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia? LC De Souza, M Chupin, M Bertoux, S Lehéricy, B Dubois, F Lamari, ... Journal of Alzheimer's disease 36 (1), 57-66, 2013 | 116 | 2013 |
| Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS P Oeckl, C Jardel, F Salachas, F Lamari, PM Andersen, R Bowser, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17 (5-6), 404-413, 2016 | 114 | 2016 |
| Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total‐tau … H Hampel, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ... Alzheimer's & Dementia 14 (4), 492-501, 2018 | 102 | 2018 |
